LISA BOUCHER: Open Payments
NPI 1730285982 · AUBURN, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 44 payments from 15 companies in 2025. Trend: 2023 $522 · 2024 $1,408 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $291 |
| AstraZeneca Pharmaceuticals LP | 11 | $190 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Novo Nordisk Inc | 4 | $73 |
| PFIZER INC. | 3 | $67 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Lundbeck LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, BREZTRI, SHINGRIX, ROTATEQ, FARXIGA, UBRELVY, BEXSERO, AIRSUPRA.
Industry payments across ME — which companies pay providers there.
